We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

11 hedge funds and large institutions have $867K invested in NeuroMetrix, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

22% more funds holding

Funds holding: 911 (+2)

43% less capital invested

Capital invested by funds: $1.52M → $867K (-$652K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q2 2018 in Review

11 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2018, worth a combined $867K — down 43% from $1.52M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NURO positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $31.1K. The largest seller was Sabby Management, cutting an estimated $505K.

  • 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2018, up from 9 in Q1 2018.
  • Funds reported $867K of NeuroMetrix, Inc. Common Stock stock for Q2 2018, down 43% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2018 and 1 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2018 was Renaissance Technologies, an estimated $31.1K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2018 was Sabby Management, an estimated $505K sold.

Based on aggregated 13F filings for Q2 2018.